Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
MRC/BHF. Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebocontrolled trial.
Lancet, 360 (2002), pp. 7-22
[2.]
Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP).
Jama, 285 (2001), pp. 2486-2497
[3.]
T. Sudhop, D. Lutjohann, A. Kodal, M. Igel, D.L. Tribble, S. Shah, et al.
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
Circulation, 106 (2002), pp. 1943-1948
[4.]
C.A. Dujovne, M.P. Ettinger, J.F. McNeer, L.J. Lipka, A.P. LeBeaut, R. Suresh.
Ezetimibe Study Group. Efficacy and safety of a potent new selective colesterol absortion inhibitor, ezetimibe, in patients with primary hypercholesterolemia.
Am J Cardiol, 90 (2002), pp. 1092-1097
[5.]
C. Gagne, H.E. Bays, S.R. Weiss, P. Mata, K. Quinto, M. Melino.
Ezetimibe Study Group. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.
Am J Cardiol, 90 (2002), pp. 1084-1091
[6.]
T.A. Miettinen, H. Gylling, N. Lindbohm, T.E. Miettinen, R.A. Rajaratnan, H. Relas.
Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins.
J Lab Clin Med, 141 (2003), pp. 131-137
Copyright © 2004. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.